SEC Form D · Amendment · filed December 23, 2019
Protagenic Therapeutics, Inc.\new
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Alexander K. Arrow · New York, NYExecRobert B. Stein · New York, NYDirectorJoshua B. Silverman · New York, NYDirectorBrian J. Corvese · New York, NYDirectorGaro H. Armen · New York, NYExec · DirectorKhalil B. Barrage · New York, NYDirectorJeffery C. Conn · The Woodlands, TXExecDean T. Kehler · New York, NYDirectorJennifer Goldfarb · San Mateo, CAExec · DirectorMarcelo Camberos · San Mateo, CADirectorChristopher T. Lacovara · New York, NYDirectorVirginia E. Riesing · MILWAUKEE, WIDirectorAlan Thielemann · Dunwoody, GAExec · DirectorAdam L. Alpert · Providence, RIDirectorNoah Rosenfarb · Parkland, FLExecRodney Wolterman · Vancouver, British Columbia, CanadaDirectorMichael Townsend · Vancouver, British Columbia, CanadaDirectorSean Cross · Frisco, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗